Investigating ELOVL7 coding variants in multiple system atrophy

Neurosci Lett. 2021 Apr 1:749:135723. doi: 10.1016/j.neulet.2021.135723. Epub 2021 Feb 15.

Abstract

Multiple system atrophy (MSA) is a rare sporadic, progressive parkinsonism characterised by autonomic dysfunction. A recent genome-wide association study reported an association at the Elongation of Very Long Fatty Acids Protein 7 (ELOVL7) locus with MSA risk. In the current study four independent and unrelated cohorts were assessed, consisting of pathologically confirmed MSA cases, Parkinson's disease (PD) cases, and two unrelated, healthy control groups. All exons of ELOVL7 were sequenced in pathologically confirmed MSA cases; data for PPMI samples and Biobank controls was extracted from whole genome sequence. Coding variants in ELOVL7 were extremely rare, and we observed no significant association of ELOVL7 coding variants with risk of MSA.

Keywords: ELOVL7; Genetics; Lipids; Multiple system atrophy; Synucleinopathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Fatty Acid Elongases / genetics*
  • Female
  • Genome-Wide Association Study
  • Humans
  • Male
  • Middle Aged
  • Multiple System Atrophy / genetics*
  • Multiple System Atrophy / pathology*
  • Parkinson Disease / genetics*
  • Polymorphism, Single Nucleotide / genetics
  • alpha-Synuclein / genetics

Substances

  • ELOVL7 protein, human
  • alpha-Synuclein
  • Fatty Acid Elongases